{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:39:47Z","timestamp":1790739587484,"version":"4.1.0"},"reference-count":104,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>In the follicular lymphoma (FL) microenvironment, CXCR5+ICOS+PD1+BCL6+ follicular helper T (Tfh) cells, which closely correlate with FL B cells in neoplastic follicles, play a major role in supporting FL. Interleukin-4 secreted by Tfh cells triggers the upregulation of the lymphocyte chemoattractant CXCL12 in stromal cell precursors, in particular by fibroblastic reticular cells (FRCs). In turn, mesenchymal stem cells (MSCs) can be committed to FRC differentiation in the bone marrow and lymph nodes involved by FL. Noteworthy, MSCs can promote the differentiation of Tfh cells into highly immunosuppressive T-follicular regulatory cells. The tumor suppressor HVEM is highly mutated in FL cells, and its deficiency increases Tfh cell frequency. In contrast, PI3K\u03b4 inhibition impedes the recruitment of Tfh\/regulatory T cells and impairs the proliferation of follicular dendritic cells (FDCs) and FDC-induced angiogenesis. Since TIGIT ligands are expressed by FDCs, the immune checkpoint receptor TIGIT plays an important role in tumor-infiltrating T cells. Thus, TIGIT blockade might invigorate cytotoxic T cells in the FL microenvironment. Given their potential to simultaneously reduce the neoplastic B cells, Tfh, and TFR cells could also reinforce the effects of the cytotoxic T cells. This combinatory strategy should be explored as a treatment option to tackle FL.<\/jats:p>","DOI":"10.3390\/ijms22105352","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T12:58:07Z","timestamp":1621429087000},"page":"5352","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The Tumor Microenvironment in Follicular Lymphoma: Its Pro-Malignancy Role with Therapeutic Potential"],"prefix":"10.3390","volume":"22","author":[{"given":"Takashi","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu City, Mie 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"25","author":"Montoto","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","article-title":"Population-based analysis of incidence and outcome of transformed non-Hodgkin\u2019s lymphoma","volume":"26","author":"Gill","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1016\/S2352-3026(18)30155-8","article-title":"Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: A 10-year follow-up analysis of the JCOG0203 trial","volume":"5","author":"Watanabe","year":"2018","journal-title":"Lancet Haematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1158\/1078-0432.CCR-14-3253","article-title":"The prognostic impact of CD163-positive macrophages in follicular lymphoma: A study from the BC cancer agency and the lymphoma study association","volume":"21","author":"Kridel","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2009-07-235598","article-title":"The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation","volume":"115","author":"Farinha","year":"2010","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","article-title":"High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma","volume":"108","author":"Carreras","year":"2006","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Yang, Z.-Z., Grote, D.M., Ziesmer, S.C., Xiu, B., Novak, A.J., and Ansell, S.M. (2015). PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival. Blood Cancer J., 5.","DOI":"10.1038\/bcj.2015.1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.4161\/cc.9.24.14322","article-title":"Alternative activation of tumor-associated macrophages by IL-4 Priming for protumoral functions","volume":"9","author":"Wang","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ni.2262","article-title":"Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks","volume":"13","author":"Malhotra","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.2426","article-title":"Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions","volume":"17","author":"Chung","year":"2011","journal-title":"Nat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.4049\/jimmunol.1101328","article-title":"Regulation of the germinal center reaction by Foxp3+ follicular regulatory T cells","volume":"187","author":"Wollenberg","year":"2011","journal-title":"J. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Brady, M.T., Hilchey, S.P., Hyrien, O., Spence, S.A., and Bernstein, S.H. (2014). Mesenchymal stromal cells support the viability and differentiation of follicular lymphoma-infiltrating follicular helper T-cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097597"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ni1513","article-title":"Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells","volume":"8","author":"Link","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1084\/jem.20160832","article-title":"Plasma cell output from germinal centers is regulated by signals from Tfh and stromal cells","volume":"215","author":"Zhang","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ni.3035","article-title":"The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture","volume":"16","author":"Astarita","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.4049\/jimmunol.1402520","article-title":"Fibroblastic reticular cells: Organization and regulation of the T lymphocyte life cycle","volume":"194","author":"Brown","year":"2015","journal-title":"J. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/ni.2112","article-title":"Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes","volume":"12","author":"Malhotra","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Knoblich, K., Migoni, S.C., Siew, S.M., Jinks, E., Kaul, B., Jeffery, H.C., Baker, A.T., Suliman, M., Vrzalikova, K., and Mehenna, H. (2018). The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation. PLoS Biol., 16.","DOI":"10.1371\/journal.pbio.2005046"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4137\/IJTR.S38355","article-title":"The kynurenine pathway Is a double-edged sword in immune-privileged sites and in cancer: Implications for immunotherapy","volume":"9","author":"Routy","year":"2016","journal-title":"Int. J. Tryptophan Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/icb.2011.75","article-title":"Prostaglandin E2 and T cells: Friends or foes?","volume":"90","author":"Sreeramkumar","year":"2011","journal-title":"Immunol. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.4049\/jimmunol.175.3.1483","article-title":"Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells","volume":"175","author":"Baratelli","year":"2005","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4049\/jimmunol.1700850","article-title":"A2A adenosine receptor gene deletion or synthetic A2A antagonist liberate tumor-reactive CD8(+) T cells from tumor-induced immunosuppression","volume":"201","author":"Kjaergaard","year":"2018","journal-title":"J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Misiak, J., Jean, R., Rodriguez, S., Deleurme, L., Lamy, T., Tarte, K., and Am\u00e9-Thomas, P. (2020). Human lymphoid stromal cells contribute to polarization of follicular T cells into IL-4 secreting cells. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.559866"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.immuni.2016.09.018","article-title":"The Integrin LFA-1 controls T follicular Helper CELL generation and maintenance","volume":"45","author":"Meli","year":"2016","journal-title":"Immunity"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Mionnet, C., Mondor, I., Jorquera, A., Loosveld, M., Maurizio, J., Arcangeli, M.-L., Ruddle, N.H., Nowak, J., Aurrand-Lions, M., and Luche, H. (2013). Identification of a new stromal cell type involved in the regulation of inflamed B cell follicles. PLoS Biol., 11.","DOI":"10.1371\/journal.pbio.1001672"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.4049\/jimmunol.1501191","article-title":"Phenotypic and morphological properties of germinal center dark zone Cxcl12-expressing reticular cells","volume":"195","author":"Rodda","year":"2015","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.immuni.2018.04.006","article-title":"Single-cell RNA sequencing of lymph node stromal cells reveals niche-associated heterogeneity","volume":"48","author":"Rodda","year":"2018","journal-title":"Immunity"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"E6826","DOI":"10.1073\/pnas.1712628115","article-title":"Identification of a new subset of lymph node stromal cells involved in regulating plasma cell homeostasis","volume":"115","author":"Huang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.immuni.2012.06.010","article-title":"Lymphotoxin-beta receptor signaling through NF-kappaB2-RelB pathway reprograms adipocyte precursors as lymph node stromal cells","volume":"37","author":"Mader","year":"2012","journal-title":"Immunity"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.celrep.2016.02.033","article-title":"Context-dependent development of lymphoid stroma from adult CD34(+) adventitial progenitors","volume":"14","author":"Sitnik","year":"2016","journal-title":"Cell Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.it.2018.02.007","article-title":"Origin and immunological functions of spleen stromal cells","volume":"39","author":"Golub","year":"2018","journal-title":"Trends Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1182\/blood-2015-04-640912","article-title":"DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma","volume":"126","author":"Amin","year":"2015","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood-2017-11-764365","article-title":"Critical influences on the pathogenesis of follicular lymphoma","volume":"131","author":"Kuppers","year":"2018","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.3109\/10428194.2015.1135432","article-title":"Analysis of dendritic cell subpopulations in follicular lymphoma with respect to the tumor immune microenvironment","volume":"57","author":"Chevalier","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/cjp2.97","article-title":"Reduced lymphotoxin-beta production by tumour cells is associated with loss of follicular dendritic cell phenotype and diffuse growth in follicular lymphoma","volume":"4","author":"Pepe","year":"2018","journal-title":"J. Pathol. Clin. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/bjh.14201","article-title":"The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era","volume":"175","author":"Blaker","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3109\/10428194.2015.1107907","article-title":"Localization of collagen modifying enzymes on fibroblastic reticular cells and follicular dendritic cells in non-neoplastic and neoplastic lymphoid tissues","volume":"57","author":"Ohe","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hon.2577","article-title":"Differential expression of estrogen receptor-alpha on follicular dendritic cells from patients with grade 1-2 and grade 3 follicular lymphoma","volume":"37","author":"Ohe","year":"2019","journal-title":"Hematol. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kurshumliu, F., Sadiku-Zehri, F., Qerimi, A., Vela, Z., Jashari, F., Bytyci, S., Rashiti, V., and Sadiku, S. (2019). Divergent immunohistochemical expression of CD21 and CD23 by follicular dendritic cells with increasing grade of follicular lymphoma. World J. Surg. Oncol., 17.","DOI":"10.1186\/s12957-019-1659-8"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/hon.2730","article-title":"Good prognosis for follicular lymphoma with estrogen receptor alpha-positive follicular dendritic cells","volume":"38","author":"Ohe","year":"2020","journal-title":"Hematol. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1056\/NEJMoa1314583","article-title":"PI3Kdelta inhibition by idelalisib in patients with relapsed indolent lymphoma","volume":"370","author":"Gopal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1182\/bloodadvances.2020001584","article-title":"PI3Kdelta inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclax","volume":"4","author":"Serrat","year":"2020","journal-title":"Blood Adv."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1200\/JCO.2016.70.4320","article-title":"Phase I first-in-human study of venetoclax in patients with relapsed or refractory non-Hodgkin lymphoma","volume":"35","author":"Davids","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12307-018-0217-1","article-title":"T-cell clustering in neoplastic follicles of follicular lymphoma","volume":"11","author":"Schnotalle","year":"2018","journal-title":"Cancer Microenviron."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2141.2012.09123.x","article-title":"A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential","volume":"158","author":"Lee","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.leu.2402002","article-title":"Establishment of a follicular lymphoma cell line (FLK-1) dependent on follicular dendritic cell-like cell line HK","volume":"15","author":"Kagami","year":"2001","journal-title":"Leukemia"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1158\/1078-0432.CCR-14-0154","article-title":"Disruption of Follicular Dendritic Cells-Follicular Lymphoma Cross-talk by the Pan-PI3K Inhibitor BKM120 (Buparlisib)","volume":"20","author":"Rodriguez","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1182\/blood-2006-05-020800","article-title":"Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: Role of stromal cells in follicular lymphoma pathogenesis","volume":"109","author":"Hajjami","year":"2007","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/leu.2008.266","article-title":"Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin\u2019s B lymphoma cells from apoptosis","volume":"23","author":"Lwin","year":"2009","journal-title":"Leukemia"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.celrep.2016.04.023","article-title":"Lymphotoxin-dependent B cell-Frc crosstalk promotes de novo follicle formation and antibody production following intestinal helminth infection","volume":"15","author":"Dubey","year":"2016","journal-title":"Cell Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.celrep.2016.12.038","article-title":"Infection programs sustained lymphoid stromal cell responses and shapes lymph node remodeling upon secondary challenge","volume":"18","author":"Gregory","year":"2017","journal-title":"Cell Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.exphem.2007.11.007","article-title":"Mesenchymal cells recruit and regulate T regulatory cells","volume":"36","author":"Moretti","year":"2008","journal-title":"Exp. Hematol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1182\/blood-2011-08-370908","article-title":"Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes","volume":"119","author":"Guilloton","year":"2012","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"16471","DOI":"10.18632\/oncotarget.4106","article-title":"Neutrophils trigger a NF-kappaB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas","volume":"6","author":"Gregoire","year":"2015","journal-title":"Oncotarget"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood-2016-08-737239","article-title":"IL-4\/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma","volume":"129","author":"Pandey","year":"2017","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1080\/10428194.2016.1263841","article-title":"An analysis of the role of follicular lymphoma-associated fibroblasts to promote tumor cell viability following drug-induced apoptosis","volume":"58","author":"Staiger","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/cas.13873","article-title":"Pyruvate secreted from patient-derived cancer-associated fibroblasts supports survival of primary lymphoma cells","volume":"110","author":"Sakamoto","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.immuni.2009.03.003","article-title":"Follicular helper T cells: Lineage and location","volume":"30","author":"Fazilleau","year":"2009","journal-title":"Immunity"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/leu.2011.301","article-title":"Characterization of intratumoral follicular helper T cells in follicular lymphoma: Role in the survival of malignant B cells","volume":"26","author":"Yssel","year":"2012","journal-title":"Leukemia"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.4049\/jimmunol.1201363","article-title":"Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment","volume":"190","author":"Rawal","year":"2013","journal-title":"J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/leu.2010.223","article-title":"Follicular lymphoma cell niche: Identification of a preeminent IL-4-dependent T(FH)-B cell axis","volume":"24","author":"Pangault","year":"2010","journal-title":"Leukemia"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3324\/haematol.2019.220160","article-title":"The architecture of neoplastic follicles in follicular lymphoma; analysis of the relationship between the tumor and follicular helper T cells","volume":"105","author":"Townsend","year":"2020","journal-title":"Haematologica"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ni.2261","article-title":"The development and fate of follicular helper T cells defined by an IL-21 reporter mouse","volume":"13","author":"Kallies","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1182\/blood-2015-02-625152","article-title":"CD10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cells","volume":"125","author":"Hoeller","year":"2015","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccell.2020.03.016","article-title":"Cathepsin S regulates antigen processing and T cell activity in non-Hodgkin lymphoma","volume":"37","author":"Dheilly","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric antigen receptor T cells in refractory B-cell lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJMc2030164","article-title":"Lymphoma Program Investigators at the University of Pennsylvania. Five-year outcomes for refractory B-cell lymphomas with CAR T-cell therapy","volume":"384","author":"Chong","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1470-2045(18)30864-7","article-title":"Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): A single-arm, multicentre, phase 1-2 trial","volume":"20","author":"Locke","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Bunse, M., Pfeilschifter, J., Bluhm, J., Zschummel, M., Joedicke, J.J., Wirges, A., Stark, H., Kretschmer, V., Chmielewski, M., and Uckert, W. (2021). CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin\u2019s lymphoma and tumor-supportive follicular T helper cells. Nat. Commun., 12.","DOI":"10.1038\/s41467-020-20488-3"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1038\/s41375-019-0464-2","article-title":"CXCR5(+)CD8(+) T cells are a distinct functional subset with an antitumor activity","volume":"33","author":"Chu","year":"2019","journal-title":"Leukemia"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.4049\/jimmunol.1001730","article-title":"Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction","volume":"185","author":"Rolf","year":"2010","journal-title":"J. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.4049\/jimmunol.178.7.4051","article-title":"Follicular lymphoma intratumoral CD4 + CD25 + GITR + regulatory T cells potently suppress CD3\/CD28-costimulated autologous and allogeneic CD8 + CD25- and CD4 + CD25- T cells","volume":"178","author":"Hilchey","year":"2007","journal-title":"J. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1182\/blood-2011-03-340646","article-title":"Follicular lymphoma tumor-infiltrating T-helper (T(H)) cells have the same polyfunctional potential as normal nodal T(H) cells despite skewed differentiation","volume":"118","author":"Hilchey","year":"2011","journal-title":"Blood"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Nedelkovska, H., Rosenberg, A.F., Hilchey, S.P., Hyrien, O., Burack, W.R., Quataert, S.A., Baker, C.M., Azadniv, M., Welle, S.L., and Ansell, S.M. (2016). Follicular lymphoma tregs have a distinct transcription profile impacting their migration and retention in the malignant lymph node. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155347"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1158\/0008-5472.CAN-15-0589","article-title":"Follicular B lymphomas generate regulatory T cells via the ICOS\/ICOSL pathway and are susceptible to treatment by anti-ICOS\/ICOSL therapy","volume":"76","author":"Le","year":"2016","journal-title":"Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cell.2016.08.032","article-title":"Loss of the HVEM tumor suppressor in lymphoma and restoration by modified CAR-T cells","volume":"167","author":"Boice","year":"2016","journal-title":"Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ni944","article-title":"BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1","volume":"4","author":"Watanabe","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.immuni.2019.05.022","article-title":"The HVEM-BTLA axis restrains T cell help to germinal center B cells and functions as a cell-extrinsic suppressor in lymphomagenesis","volume":"51","author":"Mintz","year":"2019","journal-title":"Immunity"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1158\/0008-5472.CAN-10-2460","article-title":"Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis","volume":"70","author":"Cheung","year":"2010","journal-title":"Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1182\/blood-2015-10-679191","article-title":"TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses","volume":"128","author":"Kotsiou","year":"2016","journal-title":"Blood"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.beha.2017.10.006","article-title":"Pathogenesis of follicular lymphoma","volume":"31","author":"Lackraj","year":"2018","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.19003","article-title":"High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation","volume":"59","author":"Carreras","year":"2019","journal-title":"J. Clin. Exp. Hematop."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Hutchings, M., Lugtenburg, P., Mous, R., Clausen, M.R., Chamuleau, M., Linton, K., Rule, S., Lopez, J.S., Oliveri, R.S., and DeMarco, D. (2020). Epcoritamab (GEN3013; DuoBody-CD3xCD20) to induce complete response in patients with relapsed\/refractory B-cell non-Hodgkin lymphoma (B-NHL): Complete dose escalation data and efficacy results from a phase I\/II trial. J. Clin. Oncol., 38.","DOI":"10.1200\/JCO.2020.38.15_suppl.8009"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Van der Horst, H.J., de Jonge, A.V., Hiemstra, I.H., Gelderloos, A.T., Berry, D.R.A.I., Hijmering, N.J., van Essen, H.F., de Jong, D., Chamuleau, M.E.D., and Zweegman, S. (2021). Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment. Blood Cancer J., 11.","DOI":"10.1038\/s41408-021-00430-6"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1158\/1078-0432.CCR-19-0438","article-title":"A phase I study of the combination of rituximab and ipilimumab in patients with relapsed\/refractory B-cell lymphoma","volume":"25","author":"Tuscano","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ni.2868","article-title":"Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells","volume":"15","author":"Arvey","year":"2014","journal-title":"Nat Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1172\/JCI99760","article-title":"Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy","volume":"128","author":"Goswami","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S1470-2045(20)30441-1","article-title":"Tazemetostat for patients with relapsed or refractory follicular lymphoma: An open-label, single-arm, multicentre, phase 2 trial","volume":"21","author":"Morschhauser","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/leu.2010.311","article-title":"EZH2 Y641 mutations in follicular lymphoma","volume":"25","author":"Wrench","year":"2011","journal-title":"Leukemia"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1158\/1078-0432.CCR-13-1597","article-title":"EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations","volume":"20","author":"Guo","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/j.celrep.2018.05.050","article-title":"Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity","volume":"23","author":"Wang","year":"2018","journal-title":"Cell Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.4049\/jimmunol.1701703","article-title":"The PI3K p110delta Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function","volume":"202","author":"Chellappa","year":"2019","journal-title":"J. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.19.00010","article-title":"AUGMENT: A phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma","volume":"37","author":"Leonard","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/bjh.15797","article-title":"Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma","volume":"185","author":"Chiu","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1158\/2326-6066.CIR-18-0351","article-title":"TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma","volume":"7","author":"Josefsson","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1158\/1078-0432.CCR-17-2337","article-title":"T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling","volume":"24","author":"Josefsson","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1158\/1078-0432.CCR-20-0558","article-title":"TIGIT expression is associated with T-cell suppression and exhaustion and predicts clinical outcome and anti-PD-1 response in follicular lymphoma","volume":"26","author":"Yang","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"61425","DOI":"10.18632\/oncotarget.18251","article-title":"Expression of LAG-3 defines exhaustion of intratumoral PD-1(+) T cells and correlates with poor outcome in follicular lymphoma","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.celrep.2019.01.085","article-title":"Mass cytometry analysis reveals that specific intratumoral CD4(+) T cell subsets correlate with patient survival in follicular lymphoma","volume":"26","author":"Yang","year":"2019","journal-title":"Cell Rep."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Pangault, C., Am\u00e9-Thomas, P., Rossille, D., Dulong, J., Caron, G., Nonn, C., Chatonnet, F., Desmots, F., Launay, V., and Lamy, T. (2020). Integrative analysis of cell crosstalk within follicular lymphoma cell niche: Towards a definition of the FL supportive synapse. Cancers, 12.","DOI":"10.3390\/cancers12102865"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/10\/5352\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:04:04Z","timestamp":1760162644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/10\/5352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":104,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijms22105352"],"URL":"https:\/\/doi.org\/10.3390\/ijms22105352","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]}}}